The history of sulfobutylether-beta-cyclodextrin
With this historical paper, prof. Stella and Dr. Rajevski wanted to honor to Dr. Thornstein Loftsson, Professor Emeritus at University
The history of sulfobutylether-beta-cyclodextrin
With this historical paper, prof. Stella and Dr. Rajevski wanted to honor to Dr. Thornstein Loftsson, Professor Emeritus at University
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
Amirian and Levy have recently collected the knowledge on remdesivir and its nucleoside analog [1]. This overview can be interesting
Contribution of Franz Schardinger to cyclodextrins
Prof. Crini has collected the literature on the contribution of Franz Schardinger (1853-1920), one of the pioneers, to the discovery
4th International Biotechnology Congress 2020
The 4th International Biotechnology Congress (IBC-2020) will be held during Nov. 11-13, 2020 in Dubai, UAE. Keynote speakers: Dr. Sergei
First copies of Gilead’s SBECD-enabled remdesivir to start selling in Bangladesh
According to Hindustan Times, Bangladesh’s Beximco Pharmaceuticals Ltd. has become the world’s first company to start selling the generic version
Oculis Top-Line data from Phase 2 clinical trial for OCS-01 treating inflammation and pain after cataract surgery
Oculis, the Icelandic-Swiss clinical stage boipharmaceutical company recently reported new clinical data at the Americal Society of Cataract and Refractive
Effects of water matrix constituents on micropollutant removal by activated carbon and b-cyclodextrin polymer adsorbents
The performance of adsorbents for the removal of organic micropollutants from water can be influenced by the presence of water
Cholesterol and COVID19 lethality in elderly
A new study published on the preprint server bioRxiv* in May 2020 suggests that the strikingly increased mortality in COVID-19 patients who
Self-Inclusion and Dissociation of a Bridging β‑Cyclodextrin Triplet
In a recent paper Gao et al. has published the synthesis and conformational studies of a β-CD trimer in which
Cyclo Therapeutics reports international patent application for treating Alzheimer’s
Cyclo Therapeutics reported the publication of an international patent application for the treatment of Alzheimer’s disease with HPBCD.